News

Entertainment

Movies & Series

Science & Technology

Nature & Animals

Sport

Football (Soccer)

Business & Money

Education & Personal Development

Life

Kids & Parenting

Women's Lifestyle

Fashion & Style

Men's Lifestyle

Culture & Art

Books & Literature

Hobbies

News

Entertainment

Movies & Series

Science & Technology

Nature & Animals

Sport

Football (Soccer)

Business & Money

Education & Personal Development

Life

Kids & Parenting

Women's Lifestyle

Fashion & Style

Men's Lifestyle

Culture & Art

Books & Literature

Hobbies

home
›
Ysios Capital

Ysios Capital

9 | Follower

Startups

Ysios Capital

01.10.2025

VarmX receives Phase 1 waiver from Japanese regulator – Ysios Capital

VarmX receives Phase 1 waiver from Japanese regulator PMDA for lead asset VMX-C001

Ysios Capital

01.10.2025

Tagworks Pharmaceuticals initiates Third Dose Level in Ongoing Phase 1 Clinical Trial – Ysios Capital

Tagworks Pharmaceuticals Announces Initiation of Third Dose Level in Ongoing Phase 1 Clinical Trial of TGW101 for the Treatment of Solid Tumors

Ysios Capital

01.10.2025

Xeltis poised for commercialization – Ysios Capital

Xeltis announces successful clinical data from the aXess EU pivotal trial, demonstrating the transformative potential of aXess in hemodialysis treatment.

Ysios Capital

04.10.2025

AM-Pharma Completes Enrollment in Phase 2 – Ysios Capital

AM-Pharma Completes Enrollment in Phase 2 Study of Ilofotase Alfa for Prevention of Cardiac Surgery-Associated Renal Damage